Loading
IARC estimates 525 new cancer cases and 342 cancer deaths in Maldives in 2024; the commonest new cancers are breast, trachea, bronchus and lung and lip, oral cavity. This page is assembled automatically from OnCo's data: 1 institution, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Maldives's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 76 | 35.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 50 | 12.2 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Lip, oral cavity | 43 | 9.4 | |
| Thyroid | 42 | 6.0 | Thyroid cancer |
| Colorectum | 36 | 8.4 | Colorectal cancer |
| Leukaemia | 25 | 5.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Prostate | 19 | 9.9 | Prostate cancer |
| Non-Hodgkin lymphoma | 17 | 3.5 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Liver and intrahepatic bile ducts | 16 | 3.8 | Hepatocellular carcinoma |
| Ovary | 16 | 7.9 | Ovarian cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Trachea, bronchus and lung | 49 | 12.0 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Breast | 33 | 16.4 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Lip, oral cavity | 29 | 6.7 | |
| Colorectum | 24 | 6.2 | Colorectal cancer |
| Leukaemia | 23 | 5.1 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Liver and intrahepatic bile ducts | 16 | 3.8 | Hepatocellular carcinoma |
| Ovary | 14 | 7.0 | Ovarian cancer |
| Oesophagus | 13 | 3.1 | Oesophageal cancer |
| Non-Hodgkin lymphoma | 11 | 2.7 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Stomach | 10 | 2.6 | Gastric & gastro-oesophageal junction cancer |
No trial record in OnCo lists a site in Maldives. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Maldives is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Maldives is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.